Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: The rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE)
Open Access
- 1 December 2004
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 148 (6) , 1053-1059
- https://doi.org/10.1016/j.ahj.2004.06.026
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Justifying lipid-lowering therapy in persons ≥65 years of ageThe American Journal of Cardiology, 2002
- Beyond lipid lowering: the role of statins in vascular protectionInternational Journal of Cardiology, 2002
- Cholesterol Lowering in the Elderly PopulationArchives of internal medicine (1960), 1999
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Effect of Cholesterol Reduction on Myocardial Ischemia in Patients With Coronary DiseaseCirculation, 1997
- Reduction of Transient Myocardial Ischemia With Pravastatin in Addition to the Conventional Treatment in Patients With Angina PectorisCirculation, 1996
- Silent ischemia during daily life is an independent predictor of mortality in stable angina.Circulation, 1990
- Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease.Circulation, 1988
- Transient ST-segment depression as a marker of myocardial ischemia during daily lifeThe American Journal of Cardiology, 1984
- Silent ST segment deviations and extent of coronary artery diseaseAmerican Heart Journal, 1980